Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience...
recipients
Public insurance recipients less likely to receive diabetes and obesity drug, study reveals
A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity...
